Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142852 |
| CAS No | NA |
| Mol.F. | C25H23N5O6 |
| Mol.Wt. | 489.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142853 |
| CAS No | NA |
| Mol.F. | C12H10N4O6 |
| Mol.Wt. | 306.23 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142854 |
| CAS No | NA |
| Mol.F. | C11H8N46 |
| Mol.Wt. | 292.21 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142855 |
| CAS No | NA |
| Mol.F. | C14H17N3O6 |
| Mol.Wt. | 323.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142856 |
| CAS No | NA |
| Mol.F. | C21H22N4O7 |
| Mol.Wt. | 442.43 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142857 |
| CAS No | NA |
| Mol.F. | C20H18N4O5 |
| Mol.Wt. | 394.39 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142858 |
| CAS No | NA |
| Mol.F. | C22H22N4O6 |
| Mol.Wt. | 438.44 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142859 |
| CAS No | NA |
| Mol.F. | C22H24N4O7 |
| Mol.Wt. | 456.46 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142860 |
| CAS No | NA |
| Mol.F. | C22H24N4O6 |
| Mol.Wt. | 440.46 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142861 |
| CAS No | NA |
| Mol.F. | C22H24N4O5 |
| Mol.Wt. | 424.46 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142862 |
| CAS No | NA |
| Mol.F. | C21H19ClN4O4 |
| Mol.Wt. | 426.86 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142863 |
| CAS No | NA |
| Mol.F. | C21H19ClN4O4 |
| Mol.Wt. | 426.86 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142864 |
| CAS No | NA |
| Mol.F. | C20H16Cl2N4O3 |
| Mol.Wt. | 431.27 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142865 |
| CAS No | NA |
| Mol.F. | C22H23ClN4O5 |
| Mol.Wt. | 458.90 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142866 |
| CAS No | NA |
| Mol.F. | C21H20N4O5 |
| Mol.Wt. | 408.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142867 |
| CAS No | NA |
| Mol.F. | C23H22N4O6 |
| Mol.Wt. | 450.45 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |